India’s Biocon approves plan to raise $527 million

(Reuters) -Indian biopharma firm Biocon said on Wednesday it will raise funds worth up to 45 billion rupees ($527.3 million) via issue of securities, which may include debt and selling shares to institutional investors.

($1 = 85.3420 Indian rupees)

(Reporting by Hritam Mukherjee in Bengaluru; Editing by Krishna Chandra Eluri)